
Jennifer Tingo
VerifiedUniversity of Pennsylvania · Rehabilitation Medicine
Active 2014–2024
About
Jennifer Tingo, MD, is an Associate Professor of Clinical Pediatrics (Cardiology) in the Department of Pediatrics at the Children's Hospital of Philadelphia. Her clinical expertise includes pulmonary hypertension and fetal echocardiography. She completed her undergraduate studies at The Pennsylvania State University in 2003, earned her MD from Eastern Virginia Medical School in 2007, and obtained a Master of Science in Education with a focus on Medical Education from the University of Pennsylvania in 2026. Dr. Tingo's research and clinical work focus on pediatric cardiology, with particular attention to congenital and acquired heart conditions in children. She has contributed to numerous research publications and presentations related to pediatric cardiovascular diseases, including Kawasaki disease, alveolar capillary dysplasia, and pulmonary vascular disorders.
Research topics
- Medicine
- Cardiology
- Internal medicine
- Pediatrics
- Surgery
Selected publications
International Journal of Cardiology · 2024-06-06
articleOpen accessSSRN Electronic Journal · 2024-01-01 · 1 citations
preprintOpen accessThe Journal of Pediatrics · 2024-06-13 · 8 citations
articleThe Journal of Pediatrics · 2023-06-15 · 13 citations
articleOpen accessFELLOW OUTPATIENT CLINIC: DISCONTINUING THE DISCONTINUITY
Journal of the American College of Cardiology · 2017-03-01
articlePediatric Cardiology · 2017-05-15 · 18 citations
articleOpen accessPortopulmonary hypertension in children: a rare but potentially lethal and under‐recognized disease
Pulmonary Circulation · 2017-07-01 · 13 citations
articleOpen access1st authorPortopulmonary hypertension (PoPH) is defined by the combination of portal hypertension and precapillary pulmonary arterial hypertension (PAH). Very little is known about this process in pediatric patients but prognosis is generally poor. We review our institutional experience and report on five patients with pediatric PoPH. The median age of PoPH diagnosis was six years and PAH was 14 years. PAH diagnosis was made by echocardiogram in all patients, four of whom also had cardiac catheterization. The median mean pulmonary artery pressure (mPAP) was 48.5 mmHg (interquartile range [IQR] = 46–60) with a median pulmonary vascular resistance index (PVRi) of 9 WU*M 2 (IQR = 8–22). All were acute pulmonary vasodilator testing non‐responsive. All patients received targeted therapies. Three of five patients (60%) died despite an evidence‐based approach to care. Of those who died, timing from the PoPH diagnosis to death ranged from three days to three years. Based upon our limited experience, PoPH is a disorder with significant mortality in childhood and challenges in treatment. Future research, focused on screening and early targeted treatment strategies, may alter the current dismal prognosis for these children.
Cardiac Function After Tetralogy of Fallot/Complete Atrioventricular Canal Repair
World Journal for Pediatric and Congenital Heart Surgery · 2017-03-01 · 5 citations
articleBACKGROUND: Repair of complete atrioventricular canal (CAVC) with tetralogy of Fallot (TOF) is a challenging operation increasingly being performed as a complete, primary repair in infancy. Previous studies have focused on perioperative outcomes; however, midterm valve function, ventricular function, and residual obstruction have received little attention. METHODS: We retrospectively reviewed 20 patients who underwent CAVC/TOF repair (January 2005 to December 2014). A two-patch repair was used in all patients to correct the CAVC defect. Tetralogy of Fallot repair included transannular patch in 11 (65%) patients and valve-sparing in 6 (35%) patients. RESULTS: The average age at surgery was 72 ± 122 weeks, 40% were male, and 80% had trisomy 21. Mean echo follow-up was 3.0 ± 3.0 years. There were no in-hospital or late mortalities. The rate of reoperation was 20%. At the latest follow-up, moderate left atrioventricular valve regurgitation was present in three (15%) patients and mild stenosis present in seven (35%) patients. One (5%) patient had moderate right ventricular outflow tract (RVOT) obstruction. The valve-sparing population was smaller at the time of surgery than the non-valve-sparing cohort (body surface area: 0.28 ± 0.04 vs 0.42 ± 0.11, P = .002) and less likely to have had a previous shunt (0% vs 64%, P = .01). Among the valve-sparing patients (six), at the latest follow-up, moderate pulmonary insufficiency was present in two (33%) patients. CONCLUSION: Repair of CAVC concomitant with TOF can be performed with low mortality and acceptable perioperative morbidity. Management of the RVOT remains a challenge for the long term.
Triple outlet right ventricle: a previously unknown cardiac malformation
Cardiology in the Young · 2014-04-28 · 2 citations
article1st authorCorrespondingWe present the case of an infant with three distinct outflow tracts from the right ventricle. Three outlets from the heart have been previously named the "Tritruncal Heart". We review the two previously reported cases of tritruncal hearts and describe the anatomy, diagnosis, surgical management, and outcome of our case. Embryologic implications are also discussed.
Frequent coauthors
- 25 shared
Usha Krishnan
Columbia University Irving Medical Center
- 24 shared
Steven J. Lobritto
Columbia University
- 24 shared
Erika B. Rosenzweig
Columbia University Irving Medical Center
- 9 shared
Catherine M. Avitabile
Children's Hospital of Philadelphia
- 5 shared
Kathleen Gibbs
Nationwide Children's Hospital
- 5 shared
Julie S. Glickstein
Columbia University Irving Medical Center
- 5 shared
David B. Frank
- 5 shared
Erik A. Jensen
University of Pennsylvania
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Jennifer Tingo
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup